NVO
NVO clinical trials: NOVO NORDISK A S
Every trial on ClinicalTrials.gov where NOVO NORDISK A S is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 1,719
- Trials linked
- 1,429
- As lead sponsor
- 290
- As collaborator
- 20
- Primary completions as lead sponsor, next 90 days
NVO on the catalyst calendar · NVO registry changes
- Primary completion Dec 28, 2026Sponsor estimateNo phase registeredNCT07739901Korean Real-world Study on MASLD/MASH Outcomes.Novo Nordisk A/S · MASLD/MASHActive, not recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 21, 2025ActualPhase 2NCT06409130Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With...Novo Nordisk A/S · Alcohol-related Liver DiseaseCompletedNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 19, 2025ActualPhase 3NCT06065540A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in...Novo Nordisk A/S · Type 2 Diabetes MellitusCompletedNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 12, 2027Sponsor estimatePhase 3NCT07220759Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With CagrilintideNovo Nordisk A/S · OverweightActive, not recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 11, 2027Sponsor estimatePhase 1NCT07845578A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body WeightNovo Nordisk A/S · ObesityRecruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 14, 2028Sponsor estimatePhase 1NCT07944118Examination of How the Duration of Fasting and Temporary Stopping of Zenagamtide Dosing Affect the Amount of Food Left in the Stomach in...Novo Nordisk A/S · OverweightNot yet recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 25, 2028Sponsor estimatePhase 1/Phase 2NCT07940803A Research Study of a New Medicine NNC0662-3168 for Weight Management and Type 2 DiabetesNovo Nordisk A/S · OverweightNot yet recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 29, 2028Sponsor estimatePhase 1NCT07940582A Research Study Investigating How a New Medicine NNC0721-5186 Works in Women Living With Overweight or ObesityNovo Nordisk A/S · OverweightNot yet recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 24, 2028Sponsor estimatePhase 3NCT07931599A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at...Novo Nordisk A/S · Diabetes Mellitus, Type 2Not yet recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 4, 2028Sponsor estimatePhase 3NCT07931573AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to...Novo Nordisk A/S · Type 2 DiabetesNot yet recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 31, 2028Sponsor estimatePhase 3NCT07931547A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2...Novo Nordisk A/S · Type 2 DiabetesNot yet recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 5, 2028Sponsor estimatePhase 3NCT07931495A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2...Novo Nordisk A/S · Diabetes Mellitus, Type 2Not yet recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 26, 2028Sponsor estimatePhase 1NCT07896109A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 DiabetesNovo Nordisk A/S · Diabetes Mellitus, Type 2RecruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 1, 2027Sponsor estimatePhase 1NCT07587710A Research Study Looking Into Blood Levels of the Medicine NNC0487-0111 in the Body and How Well it is Tolerated in People With Reduced...Novo Nordisk A/S · OverweightRecruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 7, 2028Sponsor estimatePhase 3NCT07533175AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose...Novo Nordisk A/S · Diabetes MellitusActive, not recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 19, 2028Sponsor estimatePhase 3NCT07400107AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight...Novo Nordisk A/S · ObesityActive, not recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 1, 2028Sponsor estimatePhase 3NCT07919405A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and...Novo Nordisk A/S · HypertensionNot yet recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 23, 2029Sponsor estimatePhase 3NCT07830732A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia ANovo Nordisk A/S · Haemophilia ARecruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT04921956Compassionate Use of Concizumab if You Have HaemophiliaNovo Nordisk A/S · Congenital HaemophiliaNo longer availableNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 20, 2025ActualPhase 3NCT06588504Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1...Novo Nordisk A/S · Diabetes Mellitus, Type 1CompletedNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 1, 2023ActualPhase 3NCT04775082SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With ObesityNovo Nordisk A/S · ObesityActive, not recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 12, 2027Sponsor estimatePhase 1NCT07829406A Study to See How Safe a New Medicine (NNC0642-1895) is in Healthy PeopleNovo Nordisk A/S · Healthy VolunteersRecruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 20, 2029Sponsor estimatePhase 4NCT07900438A Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide...Novo Nordisk A/S · Cardiovascular RiskRecruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 19, 2027Sponsor estimatePhase 1NCT06859073A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic HyperuricemiaNovo Nordisk A/S · Healthy VolunteersActive, not recruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 29, 2029Sponsor estimatePhase 3NCT07207811CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart...Novo Nordisk A/S · Transthyretin Amyloid Cardiomyopathy (ATTR CM)RecruitingNVOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 1,694 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner